Ron van Amsterdam

Head of Clinical Operations

Ron van Amsterdam, worked at Organon in the 1990s and early 2000s, where he combined his training in medical biology and his PhD in immunopharmacology to work cross-functionally designing and driving pre- and early-clinical studies and studies across all later phases of clinical drug development of an anticoagulant agent. Increasingly senior experience was gained at Pharming (immunology), Astellas (antiinfectives), Cardialysis (CRO in cardiology), and Summit Therapeutics (antibiotics). His generalist experience from Astellas and Argenx, developing asset project management functions and the professionals involved, and his involvement in strategic business discussions contributed to his appreciation of the many aspects of drug development related to clinical operations.